ONCOLOGY MEDICAL
Drug
GENZYME CORPORATION
Total Payments
$32,212
Transactions
14
Doctors
2
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2018 | $10,338 | 3 | 1 |
| 2017 | $21,874 | 11 | 1 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $11,288 | 2 | 35.0% |
| Travel and Lodging | $10,762 | 9 | 33.4% |
| Consulting Fee | $9,689 | 1 | 30.1% |
| Food and Beverage | $472.57 | 2 | 1.5% |
Ad
Manufacturing Companies
- GENZYME CORPORATION $32,212
Product Information
- Type Drug
- Total Payments $32,212
- Total Doctors 2
- Transactions 14
About ONCOLOGY MEDICAL
ONCOLOGY MEDICAL is a drug associated with $32,212 in payments to 2 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is GENZYME CORPORATION.
Payment data is available from 2017 to 2018. In 2018, $10,338 was paid across 3 transactions to 1 doctors.
The most common payment nature for ONCOLOGY MEDICAL is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($11,288, 35.0% of total).